Catalyst Wire Dossier Catalyst Wire Dossier

IL-21 NK cells

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IL-21 NK cells, covering 2026-01-09 to 2026-01-09. Get the full timeline:

Most recent: Clinical Trial Update: Trial Testing Safety of IL-21 NK Cells for Induction of R/R AML [Phase 1]

See pricing